Cellid Co., Ltd. — Investor Relations & Filings
Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 유상증자최종발행가액확정 | 2024-07-30 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2024-07-30 | Korean | |
| [발행조건확정]증권신고서(지분증권) | 2024-07-30 | Korean | |
| [기재정정]투자설명서 | 2024-07-30 | Korean | |
| [기재정정]증권신고서(지분증권) (2024.07) | 2024-07-30 | Korean | |
| [기재정정]투자설명서 | 2024-07-30 | Korean |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 8103823 | 유상증자최종발행가액확정 | 2024-07-30 | Korean | ||
| 8103821 | [기재정정]주요사항보고서(유상증자결정) | 2024-07-30 | Korean | ||
| 8103757 | [발행조건확정]증권신고서(지분증권) | 2024-07-30 | Korean | ||
| 8103747 | [기재정정]투자설명서 | 2024-07-30 | Korean | ||
| 8103518 | [기재정정]증권신고서(지분증권) (2024.07) | 2024-07-30 | Korean | ||
| 8103507 | [기재정정]투자설명서 | 2024-07-30 | Korean | ||
| 8106582 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-07-23 | Korean | ||
| 8106472 | 주식등의대량보유상황보고서(일반) | 2024-07-23 | Korean | ||
| 8119559 | 유상증자1차발행가액결정 | 2024-06-26 | Korean | ||
| 8119558 | [기재정정]주요사항보고서(유상증자결정) | 2024-06-26 | Korean | ||
| 8119385 | [발행조건확정]증권신고서(지분증권) | 2024-06-26 | Korean | ||
| 8119363 | 투자설명서 | 2024-06-26 | Korean | ||
| 8119258 | 권리락 (유상증자) | 2024-06-26 | Korean | ||
| 8121511 | 주식등의대량보유상황보고서(약식) | 2024-06-20 | Korean | ||
| 8121942 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2024-06-19 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cellid Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15056/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15056 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15056 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15056 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15056}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cellid Co., Ltd. (id: 15056)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.